7 completed, 1 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow The Epilepsy Study Consortium: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042 NPT 2042 - Photosensitive Epilepsy, Epilepsy | Phase 1 | Completed | NeuroPro Therapeutics, Inc. | 5 | 2024-08-21 | 2025-07-16 |
| Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy High dose RLS103, placebo inhaled powder, Low dose RLS103 - Epilepsy | Phase 1 | Terminated | Receptor Life Sciences | 2 | 2022-04-25 | 2024-05-02 |
| Human Epilepsy Project 2: Resistant Focal Seizures Study Epilepsy, Brain Diseases | Completed | Epilepsy Foundation of America | 157 | 2018-05-07 | 2023-09-18 | |
| Staccato Alprazolam and Photoparoxysmal Response A=Placebo, B=Inhaled Alprazolam 0.5 mg, C=Inhaled Alprazolam 1 m - Epilepsy | Phase 2 | Completed | Nova Pneuma Inc. | 5 | 2015-01-01 | 2026-04-20 |
| The Human Epilepsy Project Focal Epilepsy | Completed | NYU Langone Health | 488 | 2012-07-01 | 2021-07-06 | |
| Assessment of Suicidality in Epilepsy - Rating Tools Epilepsy | Completed | The Epilepsy Study Consortium | 200 | 2010-01-01 | 2012-03-05 | |
| Photosensitivity Proof of Concept Trial carbamazepine 400mg, levetiracetam 1000mg - Photosensitive Epilepsy | Phase 2 | Completed | The Epilepsy Study Consortium | 6 | 2009-05-01 | 2012-03-05 |
| Efficacy of YKP3089 in Patients With Photosensitive Epilepsy YKP3089, Placebo - Epilepsy | Phase 2 | Completed | SK Life Science, Inc. | 11 | 2007-08-01 | 2014-01-31 |
Epilepsy (8) · Epilepsy, Reflex (2) · Seizures (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Epilepsies, Partial (1) · Nervous System Diseases (1) · Photosensitivity Disorders (1)
Carbamazepine (1) · Cenobamate (1) · Levetiracetam (1)
United States (7) · Australia (1) · Canada (1)
Jacqueline French, M.D. (3) · Daniel Lowenstein, MD (2) · Jacqueline French, MD (2) · Ruben Kuzniecky, MD (2) · Andres Kanner, M.D. (1) · Brandy Fureman, PhD (1) · Dale Hesdorffer, PhD, MPH (1) · J Isojarvi, MD (1) · Kelly Posner, PhD (1)